Nonsteroidal treatment of autoimmune skin diseases.
This brief survey has, it is hoped, helped to ease some of the anxiety associated with the management of complex autoimmune skin disorders. The main points to remember are that there are numerous therapeutic options for each disease. I like to think of this method of therapeutics as 'informed trial and error.' One does not need to master the monitoring, side-effect profile, or dosing regimen for each of the drugs in Table 1; only a working knowledge of a few is sufficient. I hope that the readers take advantage of the many tables and caveats I have included so this article can be a ready reference for many future uses.
Fivenson
D P
DP
Department of Dermatology, Henry Ford Health Systems, Detroit, Michigan, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003240:Connective Tissue Diseases / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D010391:Pemphigoid, Bullous / Q000188:drug therapy / Q000503:physiopathology; D010392:Pemphigus / Q000188:drug therapy / Q000503:physiopathology; D011379:Prognosis; D012871:Skin Diseases / Q000188:drug therapy* / Q000503:physiopathology
D000894:Anti-Inflammatory Agents, Non-Steroidal